| Financial Year |
March 31 2023 |
| Monetary Funds |
473,557,383.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
262,079.73 |
| Accounts Receivable |
208,133,668.02 |
| Advances to Suppliers |
5,361,142.88 |
| Other Receivables |
3,650,452.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
123,319,179.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
826,561,004.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,114,562.52 |
| Investment Properties |
-- |
| Fixed Assetes |
641,870,702.76 |
| Under-construction Projects |
21,035,540.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,579,109.49 |
| R&D expenses |
-- |
| Goodwill |
203,369,767.38 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,687,926.85 |
| Other Non-Current Assets |
4,014,024.66 |
| Sub-Total of Non-Current Assets |
990,909,286.68 |
| Total Assets |
1,817,470,290.79 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
1,172,300.00 |
| Notes Payable |
-- |
| Accounts Payable |
89,504,424.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,661,179.96 |
| Taxes Payable |
3,884,546.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,341,182.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,601,083.16 |
| Sub-Total of Current Liabilities |
185,797,371.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,003,415.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,083,875.76 |
| Total Liabilities |
197,881,246.94 |
| Paid-In Capital(Or Share Stock) |
112,627,120.00 |
| Capital Surplus |
758,187,426.22 |
| Surplus Reserve |
56,313,560.00 |
| LESS:Treasury Stock |
19,251,600.96 |
| Undistributed Profits |
714,562,004.04 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,619,589,043.85 |
| Owner's Equity（Stockholder's Equity） |
1,619,589,043.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,817,470,290.79 |
